INSIDER TRANSACTIONS
| Date | Filer | Title | Type | Shares Traded | Price |
|---|---|---|---|---|---|
| May 13, 2019 |
EVP, Clinical Strategies
|
EVP, Clinical Strategies | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 35,345 | -- |
| May 13, 2019 |
EVP, Clinical Strategies
|
EVP, Clinical Strategies | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 141,379 | -- |
| Mar 11, 2019 |
EVP, Clinical Strategies
|
EVP, Clinical Strategies | Open market or private purchase of non-derivative or derivative security | 100,000 | $2.59 |
| Jul 30, 2018 |
EVP, Clinical Strategies
|
EVP, Clinical Strategies | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 48,810 | -- |
| Jul 30, 2018 |
EVP, Clinical Strategies
|
EVP, Clinical Strategies | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 71,006 | -- |
| Mar 12, 2018 |
EVP, Clinical Strategies
|
EVP, Clinical Strategies | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 50,000 | -- |
| Mar 12, 2018 |
EVP, Clinical Strategies
|
EVP, Clinical Strategies | Initial Statement of Beneficial Ownership of Securities | -- | -- |
| Mar 12, 2018 |
EVP, Clinical Strategies
|
EVP, Clinical Strategies | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 50,000 | -- |
Stock transaction information provided by EDGAR Online. Alphatec Spine, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.